Risk Warning The value of investments can fall as well as rise and any income from them is not guaranteed and you may get back less than you invested. Past performance is not a guide to future performance.

Share Price:
Up 3,636.00p
Change Today:
66.00p
Market Cap:
3,932.03m
Sector:
Pharmaceuticals & Biotechnology

Fundamentals - based on IFRS

  (Millions) (Millions) (Millions) (Millions) (Millions)
Income Statement 31-Dec-19 31-Dec-18 31-Dec-17 31-Dec-16 31-Dec-15
Continuing Operations          
Revenue 248.50 231.40 194.10 172.56 111.00
Operating Profit/(Loss) 23.30 17.00 26.30 14.05 16.00
Profit Before Tax 19.50 9.00 19.00 12.75 14.00
Profit After Tax 13.20 15.50 26.90 9.97 11.00
Discontinued Operations          
Profit After Tax n/a n/a n/a n/a n/a
Total Dividend Paid cn/a cn/a cn/a cn/a cn/a
           
Continuing EPS          
Earnings per Share - Basic 12.85p 15.14p 28.80p 10.72p 12.85p
Earnings per Share - Diluted 12.80p 15.09p 28.69p 10.66p 12.74p
Earnings per Share - Adjusted 43.60p 41.89p 37.72p 10.72p 12.85p
Continuing and Discontinued EPS          
Earnings per Share - Basic 12.85p 15.14p 28.80p 10.72p 12.85p
Earnings per Share - Diluted 12.80p 15.09p 28.69p 10.66p 12.74p
Earnings per Share - Adjusted 43.60p 41.89p 37.72p 10.72p 12.85p
Dividend per Share 10.29p 9.50p 7.33p 6.11p 5.55p
  (Millions) (Millions) (Millions) (Millions) (Millions)
Balance Sheet 31-Dec-19 31-Dec-18 31-Dec-17 31-Dec-16 31-Dec-15
Total Non-Current Assets 727.40 780.90 428.00 434.56 212.00
Net Current Assets cn/a cn/a cn/a cn/a cn/a
Total Assets 988.30 1,040.30 636.20 607.45 340.00
Total Liabilities 511.40 536.20 320.90 322.60 135.00
Net Assets 476.90 504.10 315.30 284.85 205.00
           
Shareholders Funds 476.90 504.10 313.70 283.37 203.00
Minority Interests/Other Equity n/a n/a 1.60 1.48 2.00
Total Equity 476.90 504.10 315.30 284.85 205.00

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: Forecast figures based on normalised accounts.